Potential strategy for assessing QT/QTc interval for drugs that produce rapid changes in heart rate: Electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarization.
Robert B KleimanBorje DarpoMichael ThornThomas StöhrFrank SchippersPublished in: British journal of clinical pharmacology (2020)
Remimazolam does not prolong cardiac repolarization (QTc). The methods reported here may allow assessment of the QTc effects of other drugs given by IV bolus.